RecruitingNCT02824471

Sickle Cell Disease Biofluid Chip Technology (SCD BioChip)

Studying Sickle cell anemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospitals Cleveland Medical Center
Principal Investigator
Amma Owusu-Ansah, MD
University Hospitals Cleveland Medical Center
Intervention
SCD Group(other)
Enrollment
100 target
Eligibility
12 years · All sexes
Timeline
2014 – 2028

Study locations (1)

Collaborators

Case Western Reserve University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02824471 on ClinicalTrials.gov

Other trials for Sickle cell anemia

Additional recruiting or active studies for the same condition.

See all trials for Sickle cell anemia →

← Back to all trials